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ABSTRACT 
ASSOCIATION BETWEEN HEALTH INSURANCE AND UNDIAGNOSED DIABETES: 
NHANES 2013-2016 
 
By 
 
KOMAL PATEL 
 
15th MAY 2020 
 
BACKGROUND:  Given the insidious nature of type 2 diabetes, there is a percentage of the 
population that goes undiagnosed. Studies suggest that undiagnosed population may be at 
higher risk of developing diabetes-related macrovascular and microvascular complications.  
Therefore, it is crucial to identify factors that may be associated with undiagnosed diabetes. 
Access to healthcare and other socioeconomic factors have been researched in the past; 
however, little is known regarding the role of health insurance in the screening of undiagnosed 
diabetes.   
AIM: The aim of this study is to determine the three most commonly used types of health  
insurance (Medicare, Medicaid, and Private) among American subjects with undiagnosed 
diabetes. The study also sought to determine the type of health insurance that is mostly 
associated with undiagnosed diabetes.   
METHODS: Publicly available NHANES data files for the year 2013-2016 were used for the  
analysis. SAS survey procedures were used to estimate weighted frequencies of undiagnosed 
diabetes and types of health insurance in the target population. Multivariate logistic regression 
was carried out to estimate the association between health insurance and undiagnosed diabetes.  
RESULTS:  Overall, 6.18% of the target population had undiagnosed diabetes. The prevalence 
of undiagnosed diabetes was higher among males (3.19%) and adults aged 60 and 
above (2.17%). Among those who had undiagnosed diabetes, 5.33% had health insurance, and 
less than 1%  reported a lack of health insurance. Medicare insurance was associated with 
undiagnosed diabetes (aOR 1.61, 95% 1.07 – 2.42) as compared to other health insurance. This 
finding was statistically significant at p<0.05.  
DISCUSSION: The prevalence of undiagnosed diabetes was higher in older adults aged 60 
and above. This could be attributed to the increased prevalence of diabetes in older adults in 
the US. Results also indicate that males have a higher percentage of undiagnosed diabetes as 
compared to females. Medicare was significantly associated with undiagnosed diabetes. This 
may indicate that some policy reforms are required to improve diabetes screening services in 
this program. More research is needed to understand other factors associated with undiagnosed 
diabetes and reduce its prevalence in the U.S.  
 
 
 
 
 
 
ii 
 
 
 
 
 
 
 
 
 
ASSOCIATION BETWEEN HEALTH INSURANCE AND UNDIAGNOSED DIABETES: 
NHANES 2013-2016 
 
by 
 
KOMAL PATEL 
 
BACHELOR OF DENTAL SURGERY, PANDIT BD SHARMA UNIVERSITY 
 
 
 
 
A Thesis Submitted to the Graduate Faculty 
of Georgia State University in Partial Fulfilment 
of the 
Requirements for the Degree 
 
MASTER OF PUBLIC HEALTH 
 
 
ATLANTA, GEORGIA 
30303 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iii 
 
 
 
 
 
 
 
 
 
 
APPROVAL PAGE  
 
ASSOCIATION BETWEEN HEALTH INSURANCE AND UNDIAGNOSED DIABETES: 
NHANES 2013-2016 
 
 
 
by 
 
KOMAL PATEL 
 
 
 
 
 
 
 
 
Approved:  
 
 
 
Dr. Ike Okosun 
Committee Chair  
 
 
 
Dr. Shanta R Dube 
Committee Member  
 
 
 
 
 
 
iv 
 
 
 
Acknowledgments 
 
 
 
 
I would like to thank my family for staying through the thick and thin of this academic journey. 
I am blessed to have support and love of my husband, Gaurav, who kept me motivated and 
filled with positivity. I also would like to honor the guidance and mentorship I received from 
Dr. Okosun. I truly appreciate the opportunity to have learned under you.  
Last but not least, thank you to all my batchmates, who made this experience a memorable one.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
v 
 
 
 
 
 
 
 
 
 
Author’s Statement Page  
 
 
In presenting this thesis as a partial fulfillment of the requirements for an advanced 
degree from Georgia State University, I agree that the Library of the University shall make it 
available for inspection and circulation in accordance with its regulations governing materials 
of this type. I agree that permission to quote from, to copy from, or to publish this thesis may 
be granted by the author or, in his/her absence, by the professor under whose direction it was 
written, or in his/her absence, by the Associate Dean, School of Public Health. Such quoting, 
copying, or publishing must be solely for scholarly purposes and will not involve potential 
financial gain. It is understood that any copying from or publication of this dissertation which 
involves potential financial gain will not be allowed without written permission of the author.  
 
                                                   Komal Patel  
                                           Signature of Author 
 
 
 
 
 
 
 
 
 
  
vi 
 
TABLE OF CONTENTS  
  
ACKNOWLEDGMENTS ………………………………………………………………...iv  
LIST OF TABLES………………………………………………………………………...vii  
INTRODUCTION………………………………………………………………………….1  
1.1 Background………………………………………………………………….………1  
     1.2 Research Questions………………………………………………………………....4   
  
LITERATURE REVIEW…………………………………………………………….…….6  
     2.1 Health Insurance and Undiagnosed Diabetes……………...………….…........…….6  
     2.2 Gap in the literature ………………………………………………….………..……8  
       
METHODS AND PROCEDURES…………………...........................................................9 
3.1 Data source………….………………………………………………………. …..…9  
     3.2 Sample Size…………….……………………………………...……………............9  
     3.3 Inclusion and Exclusion Criteria……………………………...................................10  
     3.4 Main Dependent and Independent Variables………………………………………10  
     3.5 Other Covariates….………………………………………………………..……….11  
     3.6 Statistical Procedures…………………………………………………….……...….14  
 . 
 RESULTS............................................................................................................................15  
     4.1 Descriptive Statistics……………………...……………………….…….…….……15  
     4.2 Results of Bivariate analysis……….……….…………………………….…….…..16  
     4.3 Results of multivariable logistics regression analysis…………………….………...18  
  
 DISCUSSION………………………..................................................................................20   
                    
     5.1 Discussion..................................................................................................................20  
     5.2 Study Limitations.......................................................................................................23  
     5.3 Policy Implications.....................................................................................................23  
     5.4 Conclusion………………………………………………………………….….……24  
  
REFERENCES................................................................................................................... ...25  
APPENDICES……………………………………………………………………………...28  
  
  
 
 
 
 
 
 
 
 
vii 
 
List of Tables 
 
Table 1. Demographics Characteristics of Target Population Stratified by Undiagnosed 
Diabetes Prevalence 
Table 2. Demographics Characteristics of Target Population Stratified by Health Insurance 
Table 3. Bivariate Analysis of the association of participant characteristics with the primary 
outcome variable, Undiagnosed diabetes. 
Table 4. Multivariate Logistic Regression Analysis for Undiagnosed Diabetes and  Health 
Insurance with other participant characteristics 
Table 5. Multivariate Logistic Regression Analysis for Undiagnosed Diabetes and  Private 
Health Insurance with other participant characteristics 
Table 6. Multivariate Logistic Regression Analysis for Undiagnosed Diabetes and  Medicare 
with other participant characteristics 
Table 7. Multivariate Logistic Regression Analysis for Undiagnosed Diabetes Medicaid with 
other participant characteristics 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 
 
CHAPTER I- INTRODUCTION 
 
 
1.1 Background  
 
 
Impact of Diabetes on the U.S. healthcare 
Type 2 diabetes is the seventh leading cause of death in the U.S.(Center for Disease Control 
and Prevention,2020). It is a metabolic disorder characterized by hyperglycemia resulting from 
defects in insulin secretion, insulin action, or both(American Diabetes Association,2009). 
Chronic hyperglycemia is often associated with “long-term damage, dysfunction, and failure 
of various organs, especially the eyes, kidneys, nerves, heart, and blood vessels”(Diagnosis and 
Classification of Diabetes Mellitus, 2003, p. s5). Type 2 diabetes accounts for approximately 
90% to 95% of all diagnosed cases of diabetes, whereas type 1 diabetes accounts for 
approximately 5-10% of all diagnosed diabetes (CDC,2019). Bullard et al. estimated that 21.0 
million adults (8.6% )of U.S. adults self-reported type 2 diabetes in the year 2016 (Bullard et 
al., 2016). The global prevalence of diabetes is also increasing with each passing year. For the 
year 2015, the International Diabetes Federation(IDF) reported that approximately 415 million 
people had diabetes worldwide. As this epidemic is growing worldwide, IDF also predicted 
that by 2034, the prevalence could reach up to 640 million (International Diabetes 
Federation,2016). For the U.S., a study by Huang, E.S. et al. have predicted that by 2034, the 
number of people with diagnosed and undiagnosed diabetes will reach up to 44.1 million 
(Huang, E. S. et al., 2009).  
The Center for Disease Control and Prevention recently published the National 
Diabetes Statistics Report 2020, providing up-to-date statistics on diabetes. The crude estimates 
presented in this report state that the prevalence of diabetes has now reached 34.2 million 
people of all ages, making up to 10.5% of the US population (National Diabetes Statistics 
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Report, 2020). Compared with the previous findings, there has been an increase in the 
prevalence of diabetes in the U.S. population over the past three years.   
 
Importance of early diagnosis of Type 2 diabetes 
Type 2 diabetes is a severe chronic disease, and as previously mentioned, it can lead to 
life-threatening complications if not detected on time. The importance of well-regulated blood 
sugar levels in the body cannot be overemphasized, primarily when it affects the body 
vasculature and results in type 2 diabetes-related morbidities(Fowler,2008). Undiagnosed 
diabetes predisposes a person to various macrovascular diseases (coronary artery disease, 
peripheral arterial disease, and stroke) and microvascular diseases (retinopathy, nephropathy, 
and neuropathy) and cancers. (Fowler, 2008; Wu, Y. et al., 2014). 
Lack of patient awareness about its diabetes status is an issue that needs to be addressed, 
as nearly half of the people with diabetes are not aware of their diabetes status. Globally, one 
in two (50.1%), or 231.9 million of the 463 million adults living with diabetes, are unaware 
that they have diabetes(Diabetes Atlas, IDF,2019). Early detection of type 2 diabetes is 
scientifically proven to control the extent of damage to the body resulting in lesser diabetes-
related morbidities in the U.S. population (Kahn, R. et al., 2010). Therefore, well-implemented 
diabetes screening services may have a tremendous impact on identifying prediabetes and type 
2 diabetes early in the stage and assist in diabetes management.  
 
Cost Implications of Diabetes in the U.S. 
Over a period of the past two decades, as the prevalence of diabetes has increased in 
United States (National Diabetes Statistics Report, 2020), the diabetes-related healthcare cost 
as also increased (Economic Costs of Diabetes in the U.S., 2018). The total estimated cost 
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of diagnosed diabetes in 2017 was $327 billion, which included $237 billion as direct medical 
costs and $90 billion for reduced productivity. Between 2012 and 2017, per-person medical 
costs associated with diabetes increased from $8,417 to $9,601(National Diabetes Statistics 
Report, 2020). A study conducted to make future projections about diabetes, and its healthcare 
expenditure predicted that the annual U.S. healthcare spending would soar from $113 billion 
to $336 billion by 2034. (Huang, E. S., Basu, et al., 2009). 
Access to healthcare and Diabetes 
In the U.S., a significant percentage(67.3%) of the total healthcare cost for diabetes care 
is provided by government insurance(mainly Medicare and Medicaid), and the rest is covered 
by private insurance(30.7%) (ADA's The Cost of Diabetes). The role of federal and state-
funded insurance programs in promoting early diagnosis of diabetes cannot be overstated. Lack 
of health insurance coverage is often found to be one of the major obstacles for the population 
reaching for preventive or disease management services. In patients with diabetes, lack of 
health insurance also leads to poor glycemic control(Zhang et al., 2012; Casagrande & Cowie, 
2012). Therefore, diabetes screening services have the potential to prevent the diabetes-related 
complications provided the health insurance programs to facilitate access to screening services. 
Reports have shown that individuals with health insurance coverage often utilize more 
preventive services than those who are uninsured. For instance, the Oregon Health Study, done 
to study the effects of Medicaid expansion on health outcomes, found that Medicaid coverage 
increased the probability of a diagnosis of diabetes and the use of diabetes medication in 
addition to other diabetes-related health services (Baicker et al., 2013). To diagnose diabetes 
in the early stages, the U.S. Preventive Services Task Force has also laid guidelines for diabetes 
screening wherein high-risk individuals are advised to get the blood sugar levels checked 
regularly.  US Preventive Services Task Force recommends screening of “all adults aged 40 to 
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70 years who are overweight or obese, or who have one or more other known risk factors for 
diabetes, such as the family history of diabetes” (Siu AL, 2015). Incorporating these guidelines 
in recent health-reforms can potentially reduce the prevalence of undiagnosed diabetes in the 
U.S. population. 
Social determinants of Health and Diabetes 
With the increasing evidence on the relation between diabetes and socioeconomic 
factors, it is crucial not to overlook other risk factors, namely low educational attainment, low 
income, employment insecurity, and poor living conditions (Hill, 2013). Socioeconomic 
factors are the latest talking points in the public health field. Socioeconomic factors are often 
addressed as social determinants of health. "Social determinants of health are the conditions in 
which people are born, grow, live, work, and age."(About Social Determinants of Health, 
World Health Organization). Social determinants of health include above-stated social risk 
factors like education, socioeconomic status, education, income in addition to access to health 
care (Artiga & Hinton, 2019). Causal pathways of the association between social determinants 
of health and type 2 diabetes are still under research. However, they are considered as potential 
contributors to the development of type 2 diabetes. Weaker social groups with a lack of access 
to health care services, healthy foods, places to exercise, and occupational opportunities, are 
more likely to pursue unhealthy lifestyle practices (Brown, 2004). 
 
1.2. Research Question and Aims 
What percentage of the population with undiagnosed diabetes have private health insurance, 
Medicare, or Medicaid? Is there an association between health insurance coverage and 
undiagnosed diabetes? 
Aim 1: To determine the distribution of types of health insurance amongst the undiagnosed 
diabetes population. 
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Null Hypothesis 1: Distribution of types of health insurance will not vary among the 
undiagnosed type 2 diabetes population.  
Alternate Hypothesis 1: Distribution of types of health insurance will vary among the 
undiagnosed type 2 diabetes population. 
 
 
Aim 2: To analyze the association between Health Insurance and undiagnosed type 2 Diabetes.  
Null  Hypothesis 2a: Health insurance status is not associated with undiagnosed type 2 
diabetes. 
Alternate Hypothesis 2a: Health insurance status is associated with undiagnosed type 2 
diabetes.  
Null Hypothesis 2b: Prevalence of undiagnosed type 2 diabetes will be more in population 
with no health insurance as compared to the population with health insurance.  
Alternate Hypothesis 2b: Prevalence of undiagnosed type 2 diabetes will be the same in 
population with no health insurance as compared to the population with health insurance.  
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CHAPTER II – LITERATURE REVIEW 
 
2.1 Health Insurance and Undiagnosed Diabetes 
Health insurance plays an essential role in attaining good health and affects one's ability 
to avail preventative services like diabetes screening(Zhang et al., 2012; Casagrande & Cowie, 
2012). The existing literature on health insurance and type 2 diabetes found that among the 
insured population, 6.9 million were undiagnosed, accounting for 27% of the total insured 
population (Dall et al., 2016). Dall and colleagues also found that among those who were 
diagnosed and insured (16.1 million), approximately 40% had poor control of diabetes. Patients 
with poor control had a $4860 higher average annual healthcare expenditure(Dall et al., 2016). 
Dall et al. study also found that this higher average of healthcare expenditure was attributed to 
a higher prevalence of neurological complications (+14%), renal complications (+14%), and 
peripheral vascular diseases (+11%) in people with diabetes. The survey data was collected 
from a national survey and medical claim analysis on medical expenditure, medications, 
recommended exams, and diabetes-related complications. The results from the Dall et al. study 
identified Alaska to have the highest estimated proportion of undiagnosed diabetes population 
(38%) in the total diabetes population. Also, the study found that 14% of the diagnosed diabetic 
population lacked medical insurance before the implementation of the Affordable Care Act. 
The authors(Dall et al.), therefore, emphasized that there is a need for improvement in diabetes 
screening and management, along with some policies that support these improvements(Dall et 
al., 2016). 
A study from the pool of existing literature also examined an association between 
access to healthcare and type 2 diabetes (Zhang X. et al., 2008). Zhang X. et al. analyzed data 
from NHANES 1999-2004 and reported that among the people with diabetes, 42% (95% 
CL:36.7-47.7) of the total uninsured patients remained undiagnosed in that period(1999-2004), 
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and 25.9% (95%CI: 22.9 –28.9) of the total insured patients were left undiagnosed in the United 
States. Zhang X. et al. indicated an association between remaining undiagnosed and not having 
health insurance (OR=1.70;95%CI:1.0-2.9) and having health insurance> 1 year 
(OR=2.60;95%CI:1.40- 5.00) (Zhang X. et al., 2008). 
More recent literature available on undiagnosed diabetes also elaborated that the 
prevalence of undiagnosed diabetes varied in different age groups and racial groups(Zhang.N 
et al.,2017). Zhang N. et al. researched to study 10-year trends in the prevalence of undiagnosed 
and diagnosed diabetes using NHANES 1999-2010. The highest proportion of undiagnosed 
diabetes was observed in Non-Hispanic Whites (72.43;p-value=0.0015) among the total 
undiagnosed diabetes population. Individuals aged< 30years observed a significantly lower 
proportion(2.58; p-value=0.0032) of undiagnosed diabetes in the total  population undiagnosed 
diabetes(Zhang.N et al.,2017). 
The National Diabetes Statistics Report(NDSR),2017 reported that overall, 9.4% of the 
total U.S. population had diabetes, but more than three times that percentage(23.8%) remained 
undiagnosed (NDSR,2017). In the light of healthcare service utilization, the American Diabetes 
Association highlighted that "people with undiagnosed diabetes who do not have health 
insurance have 60% fewer physician office visits and they have 168% more emergency 
department visits than people who have insurance"(Peterson M., 2018). 
The growing body of literature on undiagnosed diabetes and health insurance has 
helped mold the new policies to improve healthcare access. The Affordable Care Act(ACA) 
provisioned free preventative services to its enrollees, helping improved utilization of diabetes 
screening services(Kaiser Family Foundation, 2015). This new provision of ACA also 
mandated that private insurance plans cover recommended preventive services without any 
patient cost-sharing (Kaiser Family Foundation, 2015). This provision, therefore, increased the 
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case detection rates and diagnosis of type 2 diabetes(or prediabetes) on time (Burge, M. R., & 
Schade, D. S.,2014). 
 Improving healthcare access was one of the critical goals of ACA. Some studies were 
done to understand the effects of its implementation confirmed improved insurance rates. For 
example,   a cross-sectional study done by Myerson R. et al. focusing on health care coverage 
showed a reduction of the uninsured population in the diabetes population(diagnosed and 
undiagnosed both). The estimated percentage of uninsured and undiagnosed diabetes 
population in the U.S. significantly(p-value<0.01) plummeted from 25% (95% CI: 23–27) pre-
ACA to 8%(95%CI: 5-7) post-ACA ( Myerson R.et al.,2019). This group of 
researchers(Myerson R.et al.) concluded that increased health insurance coverage among 
undiagnosed patients could improve the health outcomes and help dissolve the disparities 
observed in healthcare access. The new health reforms could also help the neglected sections 
of our society ( Myerson R.et al.,2019). 
 
2.2 Gap in the literature 
Although a vast number of researches has been carried out in the past, the literature is 
scarce in including undiagnosed diabetes in the study. In order to improve the availability of 
preventive screening services for diabetes, it is crucial to understand how different types of 
insurance plans are associated with undiagnosed diabetes. Understanding the accessibility to 
screening services in these insurance plans may be a starting point to bring evidence-based 
health-reforms. Historically, the epidemiological studies have primarily used the "diagnosed" 
diabetic population as their focal point. However, this study aims to be centered on the 
"undiagnosed" diabetes in the U.S. population to bolster diabetes screening services. 
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CHAPTER III- DATA SOURCE AND METHODS 
3.1 Data source  
This study used most recently available (2013-2014 and 2015-2016) from the  National 
Health and Nutrition Examination Survey. The data was sorted by sequence number and 
merged before the analysis. Center of Disease Control and Prevention(CDC) explains the 
National Health and Nutrition Examination Survey (NHANES) as “a complex stratified 
multistage probability sample of the civilian noninstitutionalized population” of the United 
States. NHANES is conducted in partnership with the National Center for Health Statistics and 
the Center for Disease Control and Prevention. 
 
3.2 Sample Size 
 In 2013-2014, 14,332 persons were selected for NHANES from 30 different survey 
locations. Of those selected, 10,175 completed the interview, and 9,813 were examined. In 
2015-2016, 15,327 persons were selected for NHANES from 30 different survey locations. Of 
those selected, 9,971 completed the interview, and 9,544 were examined. Hispanic persons, 
Non-Hispanic black persons, Non-Hispanic Asian persons, Non-Hispanic white and 
other persons at or below 130 percent (2013-2014), and 185 percent (2015-2016) of the poverty 
level, Non-Hispanic white and other persons aged 80 years and older were oversampled in both 
the cycles. (CDC, 2020) 
The advantage of using NHANES data over other nationally representative surveys for 
this study is that it collects laboratory, questionnaire data, as well as examination data. 
NHANES's researchers collect biospecimens for laboratory analysis to provide detailed 
information about participants' health and nutritional status. For this cycle of data collection, 
the whole blood samples were tested by the Diabetes Diagnostic Laboratory at the University 
of Missouri-Columbia using the Tosoh Automated Glycohemoglobin Analyzer HLC-723G8. 
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3.3 Inclusion and Exclusion Criteria 
Inclusion: Adults aged 20 years and above who completed both, interview and examination, 
were included.  
Exclusion: Female participants between ages 20- 44 who tested positive in the laboratory 
pregnancy test or self-reported pregnant at exam were excluded to prevent gestational Diabetes 
from being mistakenly counted as Type 2 diabetes. Variable used "Pregnancy status at exam" 
(RIDEXPRG).  
 
3.4 Main Dependent and Independent Variables 
Undiagnosed Type 2 Diabetes was the main dependent variable for this study, and health 
insurance was the main independent variables studied in this study. The sample was analyzed 
for the distribution of "type of health insurance" among the undiagnosed Type 2 diabetes 
population and association between the main dependent and independent variables. 
 
Undiagnosed Type 2 Diabetes definition 
Undiagnosed type 2 diabetes was defined using NHANES question: "Have you ever been told 
by a doctor or health professional that you have diabetes or sugar diabetes?” and using the 
following criteria: 
Fasting plasma glucose (FPG) of 125 mg/dl or greater 
Oral glucose tolerance test (OGTT) value of 200 mg/dl or greater 
Glycated hemoglobin (A1c) 6.5% or greater. 
Participants who answered negatively to the above question and met at least one of the 
above-stated criteria were defined as having undiagnosed type 2 diabetes. 
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Health Insurance                                                                                                                          
Under the health insurance questionnaire, participants who answered yes to the variable 
HIQ011 which is  
“Are you covered by health insurance or some other kind of health care plan?” were categorized 
to be “Have health insurance coverage,” and those who answered no were categorized as “No 
health insurance coverage.”  
Types of health insurance were categorized using the following variables: covered by private 
insurance (HIQ031AC), covered by Medicare(HIQ031B) and covered by Medicaid 
(HIQ031D) 
Three new variables were created to define self-reported insurance type: Private Insurance, 
Medicare, and Medicaid.  
 
3.5 Other covariates 
The demographic characteristics of the targeted population were defined using variables: age 
(RIDAGEYR), gender(RIAGENDR), race(RIDRETH3), education (DMDEDUC2), and 
Annual Family income (INDFMIN2).  
Age(RIDAGEYR): Age was recorded in years at the time of screening. New categories were 
code as follows: 20- 39 years, 40- 59 years, and 60 and above.  
Gender (RIAGENDR): Gender was recorded as male and female, as reported. 
Race (RIDRETH3):  Reported race and Hispanic origin information derived from this 
variable were recoded into Non-Hispanic Whites, Non-Hispanic blacks, Non-Hispanic Asians, 
Hispanics and Others. 
Education(DMDEDUC2): This variable provides information on participants aged 20 and 
above recording, the highest grade or level of school completed, or the highest degree received. 
The categories provided were recoded to the following: Less than high school diploma; 
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High school diploma and Associates Degree; College graduate and above. 
Annual Family Income Level (INDFMIN2): Annual Family income were recoded into the 
following levels: Below 25,000; 25,000-44,999; 45,000-64,999; 65,000- 99,999; 100,000 and 
above. 
 
Potential confounding variables controlled in the analysis 
Current Smokers, obesity, physical activity, history of any other medical conditions 
(Hypertension, high cholesterol, coronary heart disease, and stroke) 
Current Smokers: Participants who answered “yes” to “Smoked at least 100 cigarettes in 
life(SMQ020)” and “Every day or Some days” to “Do you now smoke cigarettes? (SMQ040)” 
were classified as “current smokers.” Those who replied “no” to the above-mentioned 
question(SMQ020) and “not at all” to SMQ040 were classified as “Past smokers.” 
Body Mass Index (BMI): Data on BMI was gathered from the “Body measure examination” 
data file using variable “BMXBMI” expressed in units of kg/m2. Participants were categorized 
by BMI as follows: Below 30.0 as “Not obese” and above 30.0 as “Obese.”  
Vigorous Physical activity: The Physical Activity questionnaire (variable name prefix PAQ) 
is based on the Global Physical Activity Questionnaire (GPAQ) and provides respondent-level 
interview data on physical activities. Variable PAQ605 is used to record a respondent’s answer 
for “Vigorous work activity.” The response to the question asked in the questionnaire, “Does 
your work involve vigorous-intensity activity that causes large increases in breathing or heart 
rate like carrying or lifting heavy loads, digging or construction work for at least 10 minutes 
continuously?” helps provide insight about participant’s physical activity status.  
Participants who answered “yes” were recoded as “Physically active” and “no” were recoded 
as “Not physically active.” 
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History of medical conditions 
NHANES questionnaire also covers the questions related to the history of medical conditions. 
Pre-existing medical conditions can confound the relationship between Type 2 diabetes and 
health insurance; therefore, these variables were also included in the analysis.  Medical 
Conditions Questionnaire (MCQ) data file provides self-reported personal interview data on a 
broad range of health conditions and medical history. Medical conditions included in the 
analysis were: History of hypertension, history of high cholesterol, coronary heart disease, and 
stroke. 
 Hypertension: was defined using the question “Ever told you had high blood pressure 
(BPQ020)”. Those who answered “yes” were recoded as “Hypertensive” and “no” 
recoded as “Not hypertensive.” 
 High Cholesterol: was defined using the question, “Doctor told you have high 
cholesterol level (BPQ080)”.  Those who answered “yes” were recoded as “High 
Cholesterol” and “no” recoded as “No High Cholesterol.” 
 Coronary heart disease: was defined using the question “Has a doctor or other health 
professional ever told you that you had coronary heart disease? (MCQ160c)” 
Those who answered “yes” were categorized as “Yes” for that disease/condition, and 
those who “no” were categorized as “No.” 
 Stroke: was defined using the question “Has a doctor or other health professional ever 
told you that you had stroke? (MCQ160f)” Those who answered “yes” were 
categorized as “Yes” for that disease/condition, and those who “no” were categorized 
as “No.” 
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3.6 Statistical procedures 
OGTT Subsample 4 Year MEC weights were applied to the analysis in order to adjust 
for the effects of the sampling design, yielding the total sample(n) of 4,138 participants. 
Missing values [HbA1C (1101), FPG (136), and OGTT (136)] in the blood sugar tests were 
recoded to ‘0’ result observations.  
Descriptive statistics were conducted to determine demographics characteristics (age, 
gender, race, education, annual family income) of the target population for undiagnosed 
diabetes and health insurance status. The prevalence of undiagnosed diabetes was also noted 
in private health insurance, Medicaid, and Medicare. Significance between the variables was 
determined by bivariate analysis (PROC SURVEYFREQ) using the chi-squared test in 
categorical variables. Based on the results of the above-mentioned bivariate analysis, 
multivariable logistic regression was carried out using PROC SURVEYLOGISTICS. 
The variables that demonstrated a statistically significant association with the primary 
dependent variable and independent variable were controlled in all the models. Model 1 was 
constructed for undiagnosed diabetes and health insurance controlling for the potential 
confounders. Model 2 was constructed using undiagnosed diabetes and ‘private insurance’ 
along with other covariates. Model 3 used Medicare, and Model 4 used Medicaid along with 
other covariates against undiagnosed diabetes. A two-sided p-value< 0.05 was considered 
statistically significant for all analyses. 
All the statistical procedures were carried out using the Statistical Analysis System (SAS) 9.4. 
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CHAPTER IV – RESULTS 
4.1 Descriptive Statistics 
After applying sample weights, inclusion, and exclusion criteria, 4138 participants were 
eligible for this study. Among those, 535 (9%) participants had elevated HbA1C levels (6.5% 
or higher); 585 (10%) had elevated fasting plasma glucose levels (126 mg/dL or higher) and 
229 (4.45%) had elevated oral glucose tolerance test levels (200 mg/dL or higher). For the self-
reported diabetes status, 632 (10%) participants were never told by any health professional/ 
doctor that they have diabetes as compared to 3,506(90%) participants who were told by health 
professional/doctor that they diabetes. After combining the laboratory results and self-reported 
diabetes status, it was determined that 304 (6.18%) participants had undiagnosed diabetes.  
Undiagnosed Diabetes and participant’s characteristics  
The weighted descriptive statistics of participants’ characteristics are displayed in Table 
1. Participants who had health insurance coverage had a higher percentage of undiagnosed 
diabetes (5.33%) than those without health insurance (0.86%). The prevalence of undiagnosed 
diabetes was marginally higher in males (3.19%) as compared to females (2.98%), and adults 
aged 60 and above (2.74%) had a slightly higher prevalence of undiagnosed diabetes as 
compared to those between 40 to 60 years old (2.58%). The percentage of undiagnosed diabetes 
was highest in Non-Hispanic Whites (4.12%) followed Hispanics (0.93%), and Non-Hispanic 
Blacks (0.63%) among the total undiagnosed diabetes population. The percentage of 
undiagnosed diabetics was also higher in participants with college degree education (2.16%) 
in comparison to participants with education less than high school (1.17%). Participants who 
had an annual family income of less than 25,000 (1.77%) had a higher percentage of 
undiagnosed diabetes than those who had an annual family income of 65,000 and above 
(0.89%) among the total undiagnosed diabetes population.  
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Health Insurance and participant’s characteristics 
The prevalence of insured was 83.6% (3316), and uninsured was 16.4% (812) among 
the total sample population. The percentage of uninsured participants was highest in adults 
aged 20-39 years (9.26%) followed by adults aged 40-59years (5.99%) and adults aged 60 and 
above (1.13%) among the total sample population. Males (8.50%) were more likely to be 
uninsured as compared to females (7.88%). Health Insurance coverage was also found to be 
the highest in Non-Hispanic Whites (6.70%), followed by Hispanics (5.66%) and Non-
Hispanic Blacks (2.89%). Participants who attained college graduate degree or higher had the 
highest percentage of health insurance coverage (29.45%), followed by those who attained 
College or Associates degree (27.28%), high school graduate (16.82%) and education less than 
high school (10.03%) among the total sample population. The percentage of health insurance 
coverage also increased as the annual family income increased. Among those with no health 
insurance (16.40%), the percentage was highest in participants with family income less than 
25,000 (6.86%) and the least in those with annual family income above 100,000 (0.43%). (See 
Table 2) 
 
4.2 Results of Bivariate Analysis 
Undiagnosed Diabetes and participants’ characteristics 
Statistically significant association was found between undiagnosed diabetes and 
participants’ demographics variables: age (p<0.0001), education (p=0.03), an annual family 
income (p=0.01). No statistically significant association was found between undiagnosed 
diabetes and: gender (p=0.405), race (p=0.926), and health insurance(p=0.2668). Among the 
type of insurances, undiagnosed diabetes was associated with Medicare (p<0.0001). 
Other covariates that were significantly associated with undiagnosed diabetes were: 
Obesity (p=0.0002), history of hypertension (p<0.0001), history of high cholesterol 
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(p<0.0001), history of coronary heart disease (p=0.02) and history of stroke (p=0.02). No 
statistically significant association was found between undiagnosed diabetes and physical 
activity (p=0.263) and smoking(p=0.403).  
 
Health Insurance and participant’s characteristics 
Statistically significant association were found between health insurance and all 
demographics variables: age (p<0.0001), gender (p= 0.03), race (p<0.0001), education 
(p<0.0001) and annual family income (p<0.0001). Other covariates that had a statistically 
significant association with health insurance were: Smoking (p<0.0001), physical activity 
(p<0.0001), history of hypertension (p<0.0001), history of high cholesterol (p<0.0001), history 
of coronary heart disease (p<0.0001), history of stroke (p< 0.04). No statistically significant 
association was found between health insurance status and obesity (p=0.901).  
 
Unadjusted Odds Ratio 
In the unadjusted univariate models, the population aged between 20 and 40 was less 
likely to remain undiagnosed with diabetes compared to the population aged 60 and above 
(OR= 0.2; 95%CI:0.13-0.34). The analysis also revealed that the population with education 
less than high school had increased odds of remaining undiagnosed with diabetes as compared 
to the population with college graduates and above (OR=1.84;95%CI: 1.13-2.97). The odds of 
remaining undiagnosed with diabetes among those with annual family income below 25,000 
was 2.14 the odds of remaining undiagnosed with diabetes among those with annual family 
income 100,000 and above: 95% of the time, the odds ratio was between 1.21-3.01. For health 
insurance coverage, the population with no health insurance had lower odds of remaining 
undiagnosed with diabetes as compared to the population with health insurance (OR, 0.81 95% 
CI, 0.54-1.21).  
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When looking at the type of health insurance, the population with Medicare had 
increased odds of remaining undiagnosed with diabetes as compared to the population with 
other types of health insurance (OR, 2.50 95% CI, 1.83-3.42). On the contrary, the population 
covered by private health insurance had lower odds of remaining undiagnosed with diabetes as 
compared to the population covered by other types of health insurance (OR, 0.78 95% CI, 0.59-
1.03). The population covered by Medicaid also had approximately the same odds of remaining 
undiagnosed with diabetes as compared to the population covered by other types of health 
insurances (OR, 0.99 95% CI, 0.57-1.74).  (See Table 3) 
4.3 Results of Multivariable logistic regression analysis 
Adjusted Odds Ratio 
In the adjusted models, the odds of remaining undiagnosed with diabetes in participants 
with no health insurance was 1.11 the odds of remaining undiagnosed with diabetes in 
participants with health insurance (OR=1.11;95% CI:0.76-1.66). After controlling for all the 
independent variables, the odds of remaining undiagnosed with diabetes in participants with 
private insurance were 0.82 the odd of remaining undiagnosed with diabetes in participants 
with other types of health insurance (OR=0.82;95%CI: 0.60-1.12). After controlling for all the 
independent variables, the odds of remaining undiagnosed with diabetes in participants with 
Medicaid was 0.89 the odds of remaining undiagnosed with diabetes in participants with other 
types of health insurance (OR=0.89;95%CI: 0.50-1.58). Using a similar model, after 
controlling for all the independent variables, the odds of remaining undiagnosed in participants 
with Medicare was 1.61 the odds of remaining undiagnosed in participants with other types of 
health insurance (OR=1.61;95%CI:1.07-2.42). The association between undiagnosed diabetes 
and Medicare was found to be statistically significant (p-value= 0.021) In all the above models, 
annual family income was excluded from the models due to collinearity.  In the adjusted 
models, the odds of remaining undiagnosed with diabetes in participants who were obese were 
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1.79 the odds of remaining undiagnosed with diabetes in participants with health insurance 
(OR=1.79;95%CI:1.23-2.61) (p-value=0.003). (See table 4,5,6 and 7) 
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CHAPTER V- DISCUSSION 
 
5.1 Discussion 
The purpose of this thesis was to determine the prevalence of private health insurance, 
Medicare, and Medicare in the population with undiagnosed diabetes. The second aim of this 
study was to analyze the association between undiagnosed diabetes and health insurance status. 
This study also aimed to understand the association between undiagnosed diabetes and the three 
types of health insurance coverage mentioned above. Combining two cycles of NHANES, this 
thesis study used data from the year 2013-2016. Undiagnosed diabetes was defined using 
NHANES question ‘Ever told by a doctor that you have diabetes’ and blood sugar levels using 
three tests: Glycohemoglobin (HBA1C), fasting plasm glucose (FPG) or oral glucose tolerance 
test (OGTT). Those who answered ‘no’ to the question but had elevated blood sugar levels 
based on the cutoffs mentioned, were defined as having undiagnosed diabetes. This study 
focused primarily on undiagnosed diabetes and compared the findings from this group 
(undiagnosed diabetes) to the total sample population 
Overall, the results of the study suggest that participants with no health insurance have 
increased odds of remaining undiagnosed with diabetes as compared to participants with health 
insurance (aOR=1.11;95% CI: 0.73-1.69). However, the result was not statistically significant 
(p-value=0.609). Literature has shown mixed results for the association between health 
insurance coverage and undiagnosed diabetes. A previous study found evidence of the 
association between health insurance status and undiagnosed diabetes (Zhang et al., 2017). 
Zhang et al. reported ten- year trends (1999-2010) using NHANES data and found that 
participants with undiagnosed diabetes were more likely to be without health insurance (Zhang 
et al., 2017).  
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Findings from this thesis study also determined that participants belonging to low-
income groups (annual family income 25,000 and below) had an increased probability of 
remaining undiagnosed as compared to the more affluent population. Non-Hispanic Whites 
comprised of the highest percentage (4.2%) of undiagnosed diabetes among all races and 
ethnicities (6.18%) in the total undiagnosed population. These findings were comparable to the 
demographics characteristics of undiagnosed diabetes described in Diabetes in America for 
NHANES 2005-2010 (Appendix 8.32, Diabetes in America, 3rd edition). Participants with 
education below college graduate degree were more likely to remain undiagnosed with diabetes 
as compared to those with education college graduate or higher. However, after controlling for 
confounding, the association between education and undiagnosed diabetes was not statistically 
significant (p-value=0.132). The previous study exploring the relationship between education 
and diabetes have found an inverse association between education and diabetes (Borrell, Dallo, 
& White, 2006). Education level is one of the social determinants of health and previously 
associated with diabetes. However, this did not find a significant association between education 
and undiagnosed diabetes. Participants who were young adults and middle-aged (20 to 40) were 
significantly less likely to remain undiagnosed with diabetes as compared to participants aged 
60 and above (OR=0.26;95% CI: 0.15-0.44; p-value<0.0001). This finding may be explained 
by the association found between Medicare and undiagnosed diabetes in this sample. 
According to the U.S. Department of Health & Human Services (H.H.S.), Medicare is only 
available for people aged >65 and those with disabilities. Therefore, some correlation between 
age and Medicare is suspected.  
As for other types of health insurance coverage, this thesis study found that participants 
who had private health insurance or Medicaid had lower odds of remaining undiagnosed with 
diabetes as compared to those with other types of health insurance. Medicare, on the contrary, 
was significantly associated with undiagnosed diabetes. After controlling for all the 
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independent variables, the odds of remaining undiagnosed with diabetes in participants with 
Medicare was 1.61 the odds of remaining undiagnosed with diabetes in participants with other 
types of health insurance (OR=1.61;95%CI:1.07-2.42). As this study is one of a kind, literature 
is scarce to support this finding. However, patient and physician satisfaction from Medicare 
has been questionable, according to some literature (Davis K.et al, 2001). Many policymakers 
have suggested remodeling this federal program in order to improve the experiences for 
Medicare beneficiaries and lighten the administration burden on physicians accepting 
Medicare. 
The Centre of Medicare and Medicaid says Medicare is a federal health insurance 
program that has two parts: Part A and Part B. Medicare Part A covers hospital insurance, 
whereas Medicare Part B covers medical insurance. Preventative services like diabetes 
screening fall under Medicare Part B, available at a monthly premium, and is not free of cost. 
It is a limitation of the data used for this thesis that no details were available on which Medicare 
(Part A, Part B, or both) the participants possessed. Medicare has been investing in bolstering 
its preventative services. In 2005, in order to increase the utilization of preventive services, 
those who enrolled in Medicare Part- B were allowed to get ‘One-Time Initial Preventive 
physical examination (IPPE).' Although diabetes screening was not included in this one-time 
examination. Overall, this provision failed to increase preventative healthcare utilization (Ng, 
Jensen & Fritz, 2017). Other healthcare-related factors may potentially explain the increased 
prevalence of undiagnosed diabetes in Medicare beneficiaries. Recent studies have shown that 
there has been a decline in the number of primary care physicians accepting new Medicare 
patients. A survey conducted by Kaiser Family Foundation in 2015 found that most primary 
care physicians preferred accepting new privately insured patients (80%) as compared to new 
Medicare patients (72%) (Boccuti et al., 2015). The press also highlighted the issue of new-
patient acceptance. According to an article in the Wall Street Journal in 2013, it was published 
23 
 
that fewer American doctors were treating patients with Medicare due to low reimbursement 
rates that do not consider economic inflation (Beck, 2013). 
5.2. Study Limitations  
Using data from a large national survey has some limitations. Given the cross-sectional 
study design and data source, no causal inferences can be made. To handle missing values in 
the blood test reports, missing values were recoded to 0. This may have resulted in 
misclassification bias and, therefore, underestimation of undiagnosed diabetes cases. On the 
contrary, clinical recommendations require a second positive test to confirm elevated blood 
sugar level as with-in person variability in glycemic measures may affect the results. However, 
NHANES conducts laboratory tests only once as a part of this survey. Moreover, undiagnosed 
diabetes was defined using self-reported diabetes status. Therefore, the presence of recall bias 
also cannot be ruled out when considering the limitations.  
For future researches, it may be beneficial to study some other factors that can explain 
why people are staying undiagnosed even after having health insurance. Subsequent studies 
may also benefit by focusing on collecting primary data, especially if the study involves rare 
variables, i.e., undiagnosed diabetes. This finding will help the researchers identify 
‘undiagnosed type 2 diabetes’ cases with more accuracy. Qualitative studies aimed to 
understand health literacy and cultural barriers may also help understand the gap between 
diagnosed and undiagnosed diabetes. 
5.3 Policy Implications 
Like several other chronic diseases, diabetes poses a substantial economic burden on 
the U.S. healthcare system. Moreover, these direct and indirect costs associated with Type 2 
diabetes will only surge in the coming years. The clinical complications caused due to diabetes 
are preventable if the disease is detected on time. This calls for a robust healthcare system 
focused on prevention and better policies to run federal health insurance programs. In order to 
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make government insurance like Medicare and Medicaid more efficient in screening services, 
innovative policies may be put in place. Incentivizing doctors and primary care physicians may 
also revolutionize the healthcare sector and push the future towards value-based care rather 
than fee-for-service concept. Prioritizing preventative services across all types of health 
insurance is also another key to achieve good health for all. The focus should also be placed to 
address the prevailing health disparities in the country.  
5.4 Conclusion 
The results of this study suggest that a population with no health insurance has increased odds 
to remain undiagnosed as compared to those with health insurance. However, the association 
between health insurance and undiagnosed diabetes was not statistically significant. On the 
contrary, Medicare and undiagnosed diabetes were significantly associated. Moreover, the 
population with Medicare had increased odds of remaining undiagnosed as compared to the 
population with other types of insurance. This finding may prove useful when considering 
reforms in federal insurance programs like Medicare. Obesity was also found to be significantly 
associated with undiagnosed diabetes; therefore, improving awareness about diabetes 
screening in this group can be useful for future health programs.  
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APPENDIX 
 
Table 1. Demographics Characteristics of Target Population Stratified by Undiagnosed 
Diabetes Prevalence: Non-pregnant Adults age 20 and above, NHANES 2013-2016 
 
UNDIAGNOSED DIABETES (+)  
N=304 (6.18%) 
    UNDIAGNOSED DIABETES (-) 
N=3834 (93.8%) 
 
Variable N Col Percent (%) N Col Percent (%) p-value
* 
Age Groups     <0.0001 
20–39 32 0.85 1254 35.07  
40-59 110 2.58 1341 34.06  
60 and above 162 2.74 1239 24.68  
Sex     0.4057 
Males 171               3.19 1871 44.99  
Females 133 2.98 1963            48.82  
Annual Family Income 
Below 25,000                                       
25,000- 44,999 
45,000-64,999 
65,000-99,999 
100,000 and above 
 
98
69 
43 
37 
26 
 
1.77 
             1.70 
0.98 
0.77 
             0.89 
 
1069 
792 
540 
531 
609 
 
20.59 
18.58 
15.68 
16.73 
22.26 
0.0139 
Race/ethnicity     0.9267 
Non-Hispanic White 129 4.12 1540 61.05  
Non-Hispanic Black 50 0.63 720 10.85  
Non-Hispanic Asian 29 0.33 436 5.20  
Hispanic 89 0.93 1027 13.94  
Other/Multi 7 0.14 111 2.76  
Education     0.0319 
Less than High School 
HS Graduate/GED  
College/Associates Deg. 
College Grad and above 
Health Insurance 
Has health insurance 
No health insurance 
Private Insurance 
Has private Insurance 
Other/No private insurance 
Medicare                                  
Has Medicare 
Other/No Medicare 
Medicaid 
Has Medicaid 
Other/No Medicaid 
79 
78 
93 
       54 
    
      258 
46 
 
      149  
154 
 
      121 
183 
 
31 
273 
1.17 
              1.51 
2.16 
              1.32 
 
               5.33 
  0.86 
 
               3.40 
               2.77 
            
             2.18 
             3.99 
 
             0.48 
             5.69 
 
 
 
 
 
 
 
856 
828 
1130 
        1018 
 
        3058 
        766 
 
  1961 
        859 
 
        832 
       3002 
 
        417 
       3417 
14.32 
19.91 
29.71 
29.87 
 
            78.27 
15.53 
 
            57.29 
            36.52 
           
            16.80 
            77.01 
 
            7.39 
           86.42 
 
 
 
 
 
 
 
 
 
 
 
0.2975 
 
 
              
0.0699 
 
            
<0.0001           
          
0.9949 
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HTN =Hypertension 
CHL= Hypercholesteremia 
CHD= Coronary Heart Disease 
N= Unweighted frequencies 
* p-value obtained using Chi-Squared Test 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 UNDIAGNOSED DIABETES (+)     UNDIAGNOSED DIABETES (-)  
Variable N Col Percent (%) N Col Percent (%) p-value
 
Obesity 
Obese 
Not Obese 
Physical Activity 
Yes 
No 
     151 
     153 
 
     
       53 
      251 
         3.26 
         2.91 
 
 
         1.13 
        5.04 
       1435 
 2399 
 
   
         787 
 3046 
           35.40 
           58.41 
 
 
 20.80  
  73.01 
0.0002 
 
 
          
0.2632 
Ever told you have HTN 
Yes 
No 
Ever told you have high 
CHL  
Yes 
No 
Smoking 
Current Smoker 
Past Smoker 
Ever told you have CHD 
Yes 
No 
Ever told you have stroke 
Yes 
No 
          
      166 
138 
 
      141 
163 
 
       62 
      242 
 
      20 
     283 
          
     19 
    284 
 
          3.23 
          2.94 
 
         3.16 
          3.01 
 
          1.28 
          4.90 
      
            0.4 
          5.74 
 
         0.30 
         5.86 
 
        1407 
 2427 
 
       1390 
       2444 
 
        730 
       3100 
 
        162 
       3660 
 
        134 
       3699 
 
            30.49 
63.32 
 
             31.59 
62.22 
 
            17.54 
            76.27 
 
              3.23 
            90.58 
 
              2.66 
            90.15 
<0.0001 
 
 
<0.0001 
 
 
0.4030 
 
 
0.0290 
 
 
0.0261 
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Table 2. Demographics Characteristics of Target Population Stratified by Health Insurance: 
Non-pregnant Adults age 20 and above, NHANES 2013-2016 
 
HEALTH INSURANCE (+)  
N=3316 (83.60%) 
  NO HEALTH INSURANCE (-) 
N=812 (16.40%) 
 
Variable N Col Percent (%) N Col Percent (%) p-value 
Age Groups     <0.0001 
20–39 875 26.68 408 9.26  
40-59 
60 and above 
128 
1313 
30.63 
26.29 
320 
84 
5.99 
1.13 
 
Sex     0.040 
Males 1610            39.69 428 8.50  
Females 1706 43.91 384               7.88  
Annual Family Income  
Below 25,000                                       
25,000- 44,999 
45,000-64,999 
65,000-99,999 
100,000 and above 
 
827 
629 
492 
511 
615 
 
15.46 
           15.63 
           14.37 
15.87 
            22.66 
 
335 
232 
91 
57 
18 
 
6.86 
4.68 
2.32 
1.66 
0.43 
<0.0001 
Race/ethnicity         <0.0001 
Non-Hispanic White 1452 58.45 213 6.70  
Non-Hispanic Black 607 8.60 162 2.89  
Non-Hispanic Asian 396 4.76 67 0.74  
Hispanic 761 9.22 352 5.66  
Other/Multi 100 2.54 18 0.37  
Education 
Less than High School 
HS Graduate/GED  
College/Associates Deg. 
College Grad and above 
 
634 
689 
     1006 
      985 
 
10.03 
             16.82 
27.28 
             29.45 
 
298 
215 
215 
         84 
 
5.39 
4.61 
4.61 
1.77 
<0.0001 
Obesity 
Obese 
Not Obese 
Physical Activity 
Yes 
No 
     
     1287 
     2029 
 
      599 
    2717 
          
            32.31 
             51.29 
 
            17.15 
            66.44 
               
         294 
 518 
 
         238 
574 
           
             6.27 
            10.11 
 
            4.71  
            11.67 
  0.901 
 
 
<0.0001 
Ever told you have HTN 
Yes 
No 
 
Ever told you have high CHL 
Yes 
No 
 
          
     1385 
1931 
 
  
    1366 
1950 
 
 
             30.33 
53.26 
 
     
            31.85 
            51.74 
 
 
        184 
628 
 
                         
        160 
        652 
 
 
             3.33 
             13.05 
 
           
              2.83 
             13.55 
 
 <0.0001 
 
 
       
  <0.0001 
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Abbreviations 
HTN =Hypertension 
CHL= Hypercholesteremia 
CHD= Coronary Heart Disease 
CHL= Cholesterol 
N= Unweighted frequencies 
* p-value obtained using Chi-Squared Test 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Smoking 
Current Smoker 
Past Smoker 
Ever told you have CHD 
Yes 
No 
Ever told you have stroke 
Yes 
No 
     568 
    2744 
 
      
   168 
   3136 
          
     137 
    3177 
          13.94 
          69.65 
      
          
          3.48 
          80.10 
 
          2.70 
         80.89 
       224 
       588 
 
     
        12 
       799 
 
        15 
      797 
              4.92 
            11.47 
 
           
           0.16 
         16.23 
 
            0.26 
          16.13 
 <0.0001 
 
 
0.0001 
 
 
0.040 
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Table 3. Bivariate Analysis of the association of participant characteristics with main outcome 
variable, Undiagnosed diabetes in Non-Pregnant Adults ages 20-and above, NHANES (2013-
2016) 
Participant Characteristics  Unadjusted Odds Ratio  95% Confidence Interval p-value* 
Age group (years) 
20-39 
40-59 
60 and above 
 
0.21 
0.68 
Reference 
 
0.13 - 0.34 
0.48 - 0.95 
Reference 
 
<0.0001 
0.027 
Reference 
Sex 
Male 
Female 
 
1.16 
Reference 
 
0.80-1.69 
Reference 
 
0.412 
Reference 
Race 
Non-Hispanic White 
Non-Hispanic Black 
Non-Hispanic Asians 
Hispanics 
Others 
 
Reference 
0.86 
0.94 
0.99 
0.79 
 
Reference 
0.57 – 1.30 
0.54 – 1.61 
0.68 – 1.43 
0.37 – 1.72 
 
Reference 
0.471 
0.816 
0.973 
0.554 
Education 
Less than High School 
High School Graduate/GED  
College/Associates Degree 
College Graduate and above 
 
1.84 
1.71 
1.63 
Reference 
 
1.13 – 2.97 
1.08 - 2.72 
0.96 – 2.72 
Reference 
 
0.014 
0.023 
0.065 
Reference 
Annual Family Income 
Below 25,000 
25,000-44,999 
45,000-64,999 
65,000- 99,999 
100,000 and above 
 
2.15 
2.30 
1.57 
1.17 
Reference 
 
1.20 – 3.85 
1.37 – 3.85 
0.78 – 3.12 
0.55 – 2.42 
Reference 
 
0.012 
0.002 
0.201 
0.683 
Reference 
Health Insurance 
No health insurance 
Has health insurance 
 
0.81 
Reference 
 
0.54 – 1.21 
Reference 
 
0.304 
Reference 
Private Insurance 
Has private insurance 
Other/No private Insurance 
Medicare   
Has Medicare 
Other/No Medicare 
Medicaid 
Has Medicaid 
Other/No Medicaid 
 
 
 
 
0.78 
Reference 
 
2.50 
Reference 
 
1.00 
Reference 
 
 
0.59 – 1.03 
Reference 
 
1.83 – 3.43 
Reference 
 
0.57 – 1.74 
Reference 
 
0.083 
Reference 
 
<0.0001 
Reference 
 
0.994 
Reference 
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Obesity 
Obese 
Not obese 
 
1.84 
Reference 
 
1.30 – 2.61 
Reference 
 
0.001 
Reference 
Smoking 
Current Smoker 
Past Smoker 
 
1.13 
Reference 
 
0.83-1.55 
Reference 
 
0.411 
Reference 
Ever told you have Hypertension 
Yes 
No 
 
0.43 
Reference 
 
0.33 – 0.59 
Reference 
 
<0.0001 
Reference 
Ever told you have high CHL 
Yes 
No 
 
0.48 
Reference 
 
0.34 – 0.68 
Reference 
 
0.0002 
Reference 
Ever told you have CHD 
Yes 
No 
 
2.10 
Reference 
 
1.03 – 4.30 
Reference 
 
0.0409 
Reference 
Ever told you had a stroke 
Yes 
No 
 
1.78 
Reference 
 
1.03 – 3.07 
Reference 
 
0.0371 
Reference 
Abbreviations: 
GED= General Educational Development 
CHD= Coronary Heart Disease 
CHL= Cholesterol 
*p-value from Maximum Likelihood Estimates 
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Table 4. Multivariate Logistic Regression Analysis for Undiagnosed Diabetes and Health Insurance 
with other participant characteristics: Non-Pregnant Adults Age 20 and above, NHANES (2013-2016)  
Participant Characteristics Adjusted Odds Ratio  95% Confidence Interval p-value
* 
Age group (years) 
20-39 
40-59 
60 and above 
 
0.26 
0.70 
Reference 
 
0.15- 0.44 
0.48- 1.02 
Reference 
 
<0.0001 
0.066 
Reference 
Sex 
Male 
Female 
 
1.29 
Reference 
 
0.86-1.94 
Reference 
 
0.203 
Reference 
Race 
Non-Hispanic White 
Non-Hispanic Black 
Non-Hispanic Asians 
Hispanics 
Others 
 
Reference 
0.84 
1.51 
1.18 
0.76 
 
Reference 
0.54 – 1.37 
0.80 – 2.85 
0.72 – 1.92 
0.33 – 1.71 
 
Reference 
0.523 
0.187 
0.487 
0.496 
Education 
Less than High School 
High School Graduate/GED  
College/Associates Degree 
College Graduate and above 
 
0.99 
1.19 
1.16 
Reference 
 
0.52 – 1.90 
0.71 – 1.97 
0.64 – 2.06 
Reference 
 
0.132 
0.064 
0.118 
Reference 
Health Insurance 
No health insurance 
Has health insurance 
 
1.11 
Reference 
 
0.73 – 1.69 
Reference 
 
0.605 
Reference 
Obesity ǂ  
Obese 
Not obese 
 
1.79 
Reference 
 
1.23 – 2.61 
Reference 
 
0.003 
Reference 
Smoking 
Current Smoker 
Past Smoker 
 
1.27 
Reference 
 
0.88 – 1.84 
Reference 
 
0.177 
Reference 
Ever told you have Hypertension 
Yes 
No 
 
1.37 
Reference 
 
1.00 – 1.88 
Reference 
 
0.044 
Reference 
Ever told you have high cholesterol 
Yes 
No 
 
1.30 
Reference 
 
0.91– 1.86 
Reference 
 
0.135 
Reference 
Ever told you have CHD 
Yes 
No 
 
1.09 
Reference 
 
0.545– 2.13 
Reference 
 
0.791 
Reference 
Ever told you had a stroke 
Yes 
No 
 
1.10 
Reference 
 
0.63 – 1.93 
Reference 
 
0.722 
Reference 
Notes 
Abbreviations: GED= General Educational Development, CHD= Coronary Heart Disease 
Multivariate Logistic Regression Model significance level p<0.0001 
*p-value from Maximum Likelihood Estimates 
ǂ Participants considered obese when body mass index (BMI in kg/m2) of >30 and not obese when BMI<30 
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Table 5. Multivariate Logistic Regression Analysis for Undiagnosed Diabetes and Private Health 
Insurance with other participant characteristics: Non-Pregnant Adults Age 20 and above, NHANES 
(2013-2016)  
Participant Characteristics    Odds Ratio  95% Confidence Interval p-value
* 
Age group (years) 
20-39 
40-59 
60 and above 
 
0.26 
0.72 
Reference 
 
0.16 - 051 
0.53- 1.22 
Reference 
 
<0.0001 
0.083 
Reference 
Sex 
Male 
Female 
 
1.29 
Reference 
 
0.83-1.95 
Reference 
 
0.22 
Reference 
Race 
Non-Hispanic White 
Non-Hispanic Black 
Non-Hispanic Asians 
Hispanics 
Others 
 
Reference 
0.84 
1.48 
1.13 
0.75 
 
Reference 
0.53 – 1.33 
0.78 – 2.80 
0.70 – 1.82 
0.32 – 1.98 
 
Reference 
0.458 
0.213 
0.588 
0.486 
Education 
Less than High School 
High School Graduate/GED  
College/Associates Degree 
College Graduate and above 
 
1.46 
1.51 
1.47 
Reference 
 
0.82 – 2.59 
0.92 – 2.47 
0.86 – 2.52 
Reference 
 
0.182 
0.095 
0.147 
Reference 
Private Insurance 
Has private insurance 
Other/No private Insurance 
 
0.82 
Reference 
 
0.6 – 1.18 
Reference 
 
0.204 
Reference 
Obesityǂ 
Obese 
Not obese 
 
1.80 
Reference 
 
1.23 – 2.62 
Reference 
 
0.003 
Reference 
Smoking 
Current Smoker 
Past Smoker 
 
1.25 
Reference 
 
0.87 – 1.78 
Reference 
 
0.205 
Reference 
Ever told you have Hypertension 
Yes 
No 
 
1.35 
Reference 
 
0.99 – 1.85 
Reference 
 
0.056 
Reference 
Ever told you have high cholesterol 
Yes 
No 
 
1.31 
Reference 
 
0.91– 1.88 
Reference 
 
0.135 
Reference 
Ever told you have CHD 
Yes 
No 
 
1.06 
Reference 
 
0.53 – 2.11 
Reference 
 
0.851 
Reference 
Ever told you had a stroke 
Yes 
No 
 
1.077 
Reference 
 
0.61 – 1.80 
Reference 
 
0.786 
Reference 
Notes 
Abbreviations: GED= General Educational Development, CHD= Coronary Heart Disease 
Multivariate Logistic Regression Model significance level p<0.0001 
*p-value from Maximum Likelihood Estimates 
ǂ Participants considered obese when body mass index (BMI in kg/m2) of >30 and not obese when BMI<30 
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Table 6. Multivariate Logistic Regression Analysis for Undiagnosed Diabetes and  Medicare with 
other participant characteristics: Non-Pregnant Adults Age 20 and above, NHANES (2013-2016) 
Participant Characteristics    Odds Ratio  95% Confidence Interval p-value
* 
Age group (years) 
20-39 
40-59 
60 and above 
 
0.35 
0.92 
Reference 
 
0.18 – 0.67 
0.60 - 1.45 
Reference 
 
0.002 
0.732 
Reference 
Sex 
Male 
Female 
 
1.30 
Reference 
 
0.86-1.98 
Reference 
 
0.199 
Reference 
Race 
Non-Hispanic White 
Non-Hispanic Black 
Non-Hispanic Asians 
Hispanics 
Others 
 
Reference 
0.89 
1.59 
1.22 
0.74 
 
Reference 
0.56 – 1.39 
0.85 – 2.95 
0.77 – 1.95 
0.33 – 1.66 
 
Reference 
0.605 
0.135 
0.377 
0.464 
Education 
Less than High School 
High School Graduate/GED  
College/Associates Degree 
College Graduate and above 
 
1.50 
1.52 
1.50 
Reference 
 
0.84 – 2.69 
0.94 – 2.45 
0.89- 2.54 
Reference 
 
0.156 
0.083 
0.121 
Reference 
Medicare   
Has Medicare 
Other/No Medicare 
 
1.61 
Reference 
 
1.07 – 2.42 
Reference 
 
0.021 
Reference 
Obesityǂ 
Obese 
Not obese 
 
1.82 
Reference 
 
1.14 – 2.52 
Reference 
 
0.002 
Reference 
Smoking 
Current Smoker 
Past Smoker 
 
1.29 
Reference 
 
0.89 – 1.87 
Reference 
 
0.169 
Reference 
Ever told you have Hypertension 
Yes 
No 
 
1.34 
Reference 
 
0.98 – 1.83 
Reference 
 
0.061 
Reference 
Ever told you have high cholesterol 
Yes 
No 
 
1.28 
Reference 
 
0.89 – 1.83 
Reference 
 
0.169 
Reference 
Ever told you have CHD 
Yes 
No 
 
1.02 
Reference 
 
0.52 – 2.02 
Reference 
 
0.933 
Reference 
Ever told you had a stroke 
Yes 
No 
 
1.05 
Reference 
 
0.59 – 1.8 
Reference 
 
0.861 
Reference 
Notes 
Abbreviations: GED= General Educational Development, CHD= Coronary Heart Disease 
Multivariate Logistic Regression Model significance level p<0.0001 
*p-value from Maximum Likelihood Estimates 
ǂ Participants considered obese when body mass index (BMI in kg/m2) of >30 and not obese when BMI<30 
 
 
 
 
 
 
 
37 
 
Table 7. Multivariate Logistic Regression Analysis for Undiagnosed Diabetes and Medicaid with 
other participant characteristics: Non-Pregnant Adults Age 20 and above, NHANES (2013-2016) 
Participant Characteristics    Odds Ratio  95% Confidence Interval p-value
* 
Age group (years) 
20-39 
40-59 
60 and above 
 
0.26 
0.71 
Reference 
 
0.16 - 051 
0.53- 1.22 
Reference 
 
<0.0001 
0.069 
Reference 
Sex 
Male 
Female 
 
1.28 
Reference 
 
0.83-1.95 
Reference 
 
0.215 
Reference 
Race 
Non-Hispanic White 
Non-Hispanic Black 
Non-Hispanic Asians 
Hispanics 
Others 
 
Reference 
0.88 
1.53 
1.21 
0.77 
 
Reference 
0.50 – 1.42 
0.77 – 2.94 
0.73– 1.83 
0.32 – 2.03 
 
Reference 
0.589 
0.171 
0.399 
0.515 
Education 
Less than High School 
High School Graduate/GED  
College/Associates Degree 
College Graduate and above 
 
1.50 
1.57 
1.53 
Reference 
 
0.89 – 2.75 
0.97 – 2.55 
0.89– 2.61 
Reference 
 
0.113 
0.063 
0.115 
Reference 
Medicaid 
Other/No Medicaid 
Has Medicaid 
 
0.89 
Reference 
 
0.49 – 1.58 
Reference 
 
0.682 
Reference 
Obesity ǂ 
Obese 
Not obese 
 
1.78 
Reference 
 
1.22 – 2.55 
Reference 
 
0.003 
Reference 
Smoking 
Current Smoker 
Past Smoker 
 
1.30 
Reference 
 
0.91 – 1.85 
Reference 
 
0.136 
Reference 
Ever told you have Hypertension 
Yes 
No 
 
1.37 
Reference 
 
1.00 – 1.87 
Reference 
 
0.047 
Reference 
Ever told you have high cholesterol 
Yes 
No 
 
1.29 
Reference 
 
0.90– 1.85 
Reference 
 
0.151 
Reference 
Ever told you have CHD 
Yes 
No 
 
1.09 
Reference 
 
0.55 – 2.13 
Reference 
 
0.794 
Reference 
Ever told you had a stroke 
Yes 
No 
 
1.11 
Reference 
 
0.64 – 1.92 
Reference 
 
0.691 
Reference 
Notes 
Abbreviations: GED= General Educational Development, CHD= Coronary Heart Disease 
Multivariate Logistic Regression Model significance level p<0.0001 
*p-value from Maximum Likelihood Estimates 
ǂ Participants considered obese when body mass index (BMI in kg/m2) of >30 and not obese when BMI<30 
 
 
